BG Medicine, Merck in biomarker deal

Merck & Co. Inc. (NYSE:MRK) partnered with BG Medicine Inc. (Waltham, Mass.) to develop and validate an undisclosed biomarker for use in an in vitro diagnostic for lipid disorders. BG Medicine, which...